The Association Of The British Pharmaceutical Industry

The Association of the British Pharmaceutical Industry (ABPI) is a leading organization that represents innovative research-based biopharmaceutical companies, large, medium, and small, based in the United Kingdom. Our primary objective is to support our member companies in delivering medicines and vaccines that transform patients' lives, raise productivity, and contribute to the UK's economic growth.

The ABPI is committed to promoting an environment where the pharmaceutical industry can discover, develop, and manufacture medicines and vaccines to the highest possible standards, and make them accessible to patients across the UK and globally. Our work focuses on fostering collaboration between industry, the National Health Service (NHS), patient organizations, academia, and government bodies. We are dedicated to driving forward innovation, ensuring appropriate and timely access to medicines, upholding the highest ethical standards, and enhancing the reputation of the industry.

Our Focus

Our focus is categorized into five main areas: International, Trade and IP, Working in Partnership, Valuing and Accessing Medicines, and Research, Development and Manufacturing. These categories encompass the following:

• *International, Trade and IP*: We work to promote the UK as an attractive destination for international research and development, protect intellectual property rights, and facilitate international trade.
• *Working in Partnership*: We collaborate with various stakeholders, including the NHS, patient organizations, and academia, with the aim of maximizing innovation and ensuring widespread access to new treatments.
• *Valuing and Accessing Medicines*: Our goal is to demonstrate the value of medicines and vaccines, promote appropriate prescribing, and ensure timely access to advanced therapies, combinations, and vaccines for patients.
• *Research, Development and Manufacturing*: We strive to build a thriving environment for medicine discovery by supporting clinical research, manufacturing, regulatory science, and genomics in healthcare and research.

Building a Thriving Environment for Medicine Discovery

The ABPI is dedicated to creating an optimal environment for the discovery and development of new medicines and vaccines. This involves championing clinical research, manufacturing and quality, regulatory science, and pharmacovigilance. We believe that the UK has the potential to be the best place in the world for medicine discovery and development, and we work tirelessly to realize this vision.

Maximizing Innovation and Access for Patients

We are committed to facilitating collaboration between industry, the NHS, patient organizations, and academia, in order to maximize innovation and ensure wider access to new treatments for patients. Through initiatives such as the NHS-Industry Partnership and the ABPI Patient Advisory Council, we aim to foster meaningful dialogue and cooperation within the life sciences sector.

Transforming Lives and Raising Productivity

Medicines and vaccines bring substantial value to NHS patients and contribute significantly to the UK's economic growth. The development of new medicines and vaccines is a costly and uncertain process, involving significant rates of failure. Despite these challenges, the pharmaceutical industry invests $160 billion per year on research and development, with companies needing to make a profit and a return on investment in order to maintain future innovation.